BSJ-04-132 is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It functions as a potent and selective inhibitor, targeting specific enzymes or proteins involved in the growth and proliferation of cancer cells. Researchers employ BSJ-04-132 to investigate its potential in disrupting signaling pathways that are crucial for tumor survival. This compound is often used in preclinical studies to evaluate its efficacy and safety, providing valuable insights for the development of novel anticancer drugs. Additionally, BSJ-04-132 serves as a tool compound in biochemical assays to better understand the mechanisms of action of targeted therapies in oncology. Its application extends to the exploration of combination therapies, where it may enhance the effectiveness of existing treatments or overcome drug resistance in certain cancers.